Adaptive Biotechnologies Corp
Biotechnology
Healthcare
ADPT
148 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
7.37
52 week high
8.66
high
8.61
52 week low
3.08
low
7.30
growth
142.90 %
previous Close
7.67
P/E ratio
market cap
943 M
div yield
0
usd
Sep 2024
qoq
revenue
46.44 M
7.51 %
net incoming
-32.07 M
30.62 %
eps
0.00 %
29.03 %
eps surprise
24.14 %
net profit margin
-69.07 %
37.00 %
operating incoming
-32.63 M
17.25 %
net change in cash
-18.76 M
-64.45 %
cash on hand
38.08 M
-36.34 %
cost of revenue
16.67 M
-24.59 %
top top